Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.56 – $0.69
3% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $78.42B | $82.72B | $68.07B | $74.45B | $91.93B | $100.85B | $107.87B | $111.42B |
| Cost of revenue | $51.55B | $54.28B | $46.37B | $49.46B | $58.33B | $63.41B | $68.07B | $72.53B |
| Gross profit | $26.87B | $28.45B | $21.70B | $24.99B | $33.60B | $37.44B | $39.80B | $38.89B |
| Gross margin | 34.3% | 34.4% | 31.9% | 33.6% | 36.6% | 37.1% | 36.9% | 34.9% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $13.54B | $13.18B | $10.96B | $11.23B | $16.99B | $18.94B | $20.51B | $18.45B |
| EBITDA | $18.94B | $26.52B | $17.68B | $17.64B | $23.06B | $25.05B | $26.90B | $25.29B |
| Net income | $9.19B | $15.52B | $7.21B | $7.94B | $12.61B | $14.38B | $15.99B | $15.84B |
| Net margin | 11.7% | 18.8% | 10.6% | 10.7% | 13.7% | 14.3% | 14.8% | 14.2% |
| EPS (diluted) | 0.59 | 0.99 | 0.45 | 0.50 | 0.79 | 0.90 | 1.01 | 1.00 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $115.6B | $0.00 | $0.00–$0.00 | 0 |
| 2027 | $121.7B | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
BANGKOK DUSIT MED SVC NEW
No one on the platform currently holds BDULF.
No tracked institution reports a position in BDULF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-03-11 | $0.4000 | 2026-04-24 |
| 2026-03-11 | $0.2500 | 2026-04-24 |
| 2025-09-10 | $0.3500 | 2025-09-25 |
| 2025-03-13 | $0.4000 | 2025-04-25 |
| 2024-09-11 | $0.3500 | 2024-09-25 |
| 2024-03-06 | $0.3500 | 2024-04-22 |
| 2023-09-12 | $0.3500 | 2023-09-29 |
No one on the platform has traded BDULF yet.
| +0.00% |
| $5.7B |
| — |
| MTHRYM3, Inc. | $5.53 | -0.54% | $7.4B | — |
| RCDTFRecordati S.p.A. | $58.00 | +0.00% | $11.8B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.5× earnings vs its 0.8× historical median P/E.
Fair value ≈ $0.86 · price $0.56 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.